Abstract
Integrins are major extracellular matrix (ECM) receptors that can also serve for some cell–cell interactions. They have been identified as important regulators of mammary epithelial cell growth and differentiation. Their ability to promote cell anchorage, proliferation, survival, migration, and the induction of active ECM-degrading enzymes suggests that they play an essential role in normal mammary morphogenesis, but, on the other hand, reveals their potential to promote tumor progression.
Similar content being viewed by others
REFERENCES
R. O. Hynes (2002). Integrins: Bidirectional, allosteric signaling machines. Cell 110: 673–687.
F. G. Giancotti and E. Ruoslahti (1999). Integrin signaling. Science 285: 1028–1032.
F. G. Giancotti and G. Tarone (2003). Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu. Rev. Cell Dev. Biol. 19: 173–206.
C. K. Miranti and J. S. Brugge (2002). Sensing the environment: A historical perspective on integrin signal transduction. Nat. Cell Biol. 4: E83-E90.
G. M. Edwards, F. H. Wilford, X. Liu, L. Hennighausen, J. Djiane, and C. H. Streuli (1998). Regulation of mammary differentiation by extracellular matrix involves protein-tyrosine phosphatases. J. Biol. Chem. 273: 9495–9500.
C. H. Streuli, G. M. Edwards, M. Delcommenne, C. B. Whitelaw, T. G. Burdon, C. Schindler, et al. (1995). Stat5 as a target for regulation by extracellular matrix. J. Biol. Chem. 270: 21639–21644.
S. Z. Haslam and T. L. Woodward (2001). Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland. Breast Cancer Res. 3: 365–372.
L. Shaw (1999). Integrin function in breast carcinoma progression. J. Mammary Gland Bio. Neoplasia 4: 367–376.
T. L. Woodward, A. S. Mienaltowski, R. R. Modi, J. M. Bennet, and S. Z. Haslam (2001). Fibronectin and the alpha(5)beta(1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 142: 3214–3222.
M. Delcommenne and C. H. Streuli (1995). Control of integrin expression by extracellular matrix. J. Biol. Chem. 270: 26794–26801.
R. Y. Huang and M. M. Ip (2001). Differential expression of integrin mRNAs and proteins during normal rat mammary gland development and in carcinogenesis. Cell Tissue Res. 303: 69–80.
P. J. Keely, J. E. Wu, and S. A. Santoro (1995). The spatial and temporal expression of the alpha 2 beta 1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation 59: 1–13.
J. M. Prince, T. C. Klinowska, E. Marshman, E. T. Lowe, U. Mayer, J. Miner, et al. (2002). Cell-matrix interactions during development and apoptosis of the mouse mammary gland in vivo. Dev. Dyn. 223: 497–516.
T. Iype, K. Jayasree, and P. R. Sudhakaran (2001). Modulation of alpha2beta1 integrin changes during mammary gland development by beta-oestradiol. Biochim. Biophys. Acta 1499: 232–241.
C. Forster, S. Makela, A. Warri, S. Kietz, D. Becker, K. Hultenby, et al. (2002). Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc. Natl. Acad. Sci. U.S.A. 99: 15578–15583.
V. Novaro, C. D. Roskelley, and M. J. Bissell (2003). Collagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells. J. Cell Sci. 116: 2975–2986.
M. A. Deugnier, E. P. Moiseyeva, J. P. Thiery, and M. A. Glukhova (1995). Myoepithelial cell differentiation in the developing mammary gland: progressive acquisition of smooth muscle phenotype. Dev. Dyn. 204: 107–117.
R. Suzuki, A. J. Atherton, M. J. O'Hare, A. Entwistle, S. R. Lakhani, and C. Clarke (2000). Proliferation and differentiation in the human breast during pregnancy. Differentiation 66: 106–115.
R. N. Suzuki, A. Entwistle, A. J. Atherton, C. Clarke, S. R. Lakhani, and M. J. O'Hare (2002). The expression patterns of integrin subunits on human breast tissues obtained during pregnancy. Cell Biol. Int. 26: 593–598.
M. A. Schwartz and R. K. Assoian (2001). Integrins and cell proliferation: regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. J. Cell Sci. 114: 2553–2560.
N. Boudreau, C. J. Sympson, Z. Werb, and M. J. Bissell (1995). Supression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267: 891–893.
A. P. Gilmore, A. D. Metcalfe, L. H. Romer, and C. H. Streuli (2000). Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J. Cell Biol. 149: 431–446.
P. Wang, A. J. Valentijn, A. P. Gilmore, and C. H. Streuli (2003). Early events in the anoikis program occur in the absence of caspase activation. J. Biol. Chem. 278: 19917–19925.
M. J. Reginato, K. R. Mills, J. K. Paulus, D. K. Linch, D. C. Sgroi, J. Debnath, et al. (2003). Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat. Cell Biol. 6: 6.
S. R. Datta, A. Brunet, and M. E. Greenberg (1999). Cellular survival: A play in three Akts. Genes Dev. 13: 2905–2927.
N. Farrelly, Y. J. Lee, J. Oliver, C. Dive, and C. H. Streuli (1999). Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J. Cell. Biol. 144: 1337–1348.
Y. J. Lee and C. H. Streuli (1999). Extracellular matrix selectively modulates the response of mammary epithelial cells to different soluble signaling ligands. J. Biol. Chem. 274: 22401–22408.
V. M. Weaver, O. W. Petersen, F. Wang, C. A. Larabell, P. Briand, C. Damsky, et al. (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137: 231–245.
V. M. Weaver, S. Lelievre, J. N. Lakins, C. A. Larabell, P. Briand, C. Damsky, et al. (2002). Beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2: 205–216.
F. Wang, V. M. Weaver, O. W. Petersen, C. A. Larabell, S. Dedhar, P. Briand, et al. (1998). Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology. Proc. Natl. Acad. Sci. U.S.A. 95: 14821–14826.
F. Wang, R. K. Hansen, D. Radisky, T. Yoneda, M. H. Barcellos-Hoff, O. W. Petersen, et al. (2002). Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J. Natl. Cancer Inst. 94: 1494–1503.
M. M. Faraldo, M. A. Deugnier, M. Lukashev, J. P. Thiery, and M. A. Glukhova (1998). Perturbation of beta1-integrin function alters the development of murine mammary gland. Embo. J. 17: 2139–2147.
M. M. Faraldo, M. A. Deugnier, J. P. Thiery, and M. A. Glukhova (2001). Growth defects induced by perturbation of {beta}1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the Shc and Akt pathways. EMBO Rep. 2: 431–437.
V. L. Seewaldt, K. Mrozek, R. Sigle, E. C. Dietze, K. Heine, D. M. Hockenbery, et al. (2001). Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis. J. Cell Biol. 155: 471–486.
R. E. Bachelder, A. Marchetti, R. Falcioni, S. Soddu, and A. M. Mercurio (1999). Activation of p53 function in carcinoma cells by the alpha6beta4 integrin. J. Biol. Chem. 274: 20733–20737.
L. Hennighausen and G. W. Robinson (2001). Signaling pathways in mammary gland development. Dev. Cell 1: 467–475.
C. H. Streuli, C. Schmidhauser, N. Bailey, P. Yurchenco, A. P. Skubitz, C. Roskelley, et al. (1995). Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129: 591–603.
J. Muschler, A. Lochter, C. D. Roskelley, P. Yurchenco, M. J. Bissell (1999). Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol. Biol. Cell 10: 2817–2828.
M. M. Faraldo, M. A. Deugnier, S. Tlouzeau, J. P. Thiery, and M. A. Glukhova (2002). Perturbation of beta1-integrin function in involuting mammary gland results in premature dedifferentiation of secretory epithelial cells. Mol. Biol. Cell 13: 3521–3531.
S. Geymayer and W. Doppler (2000). Activation of NF-kappaB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression. Faseb J. 14: 1159–1170.
H. Gardner, J. Kreidberg, V. Koteliansky, and R. Jaenisch (1996). Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev. Biol. 175: 301–313.
J. Chen, T. G. Diacovo, D. G. Grenache, S. A. Santoro, and M. M. Zutter (2002). The alpha(2) integrin subunit-deficient mouse: A multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am. J. Pathol. 161: 337–344.
T. C. Klinowska, C. M. Alexander, E. Georges-Labouesse, R. Van der Neut, J. A. Kreidberg, C. J. Jones, et al. (2001). Epithelial development and differentiation in the mammary gland is not dependent on alpha 3 or alpha 6 integrin subunits. Dev. Biol. 233: 449–467.
M. E. El-Sabban, A. J. Sfeir, M. H. Daher, N. Y. Kalaany, R. A. Bassam, and R. S. Talhouk (2003). ECM-induced gap junctional communication enhances mammary epithelial cell differentiation. J. Cell Sci. 116: 3531–3541.
M. A. Deugnier, M. M. Faraldo, P. Rousselle, J. P. Thiery, and M. A. Glukhova (1999). Cell-extracellular matrix interactions and EGF are important regulators of the basal mammary epithelial cell phenotype. J. Cell Sci. 112: 1035–1044.
B. S. Wiseman and Z. Werb (2002). Stromal effects on mammary gland development and breast cancer. Science 296: 1046–1049.
F. Berdichevsky, D. Alford, B. D'Souza, and J. Taylor-Papadimitriou (1994). Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci. 107: 3557–3566.
S. Stahl, S. Weitzman, and J. C. Jones (1997). The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. J. Cell Sci. 110: 55–63.
T. Gudjonsson, L. Ronnov-Jessen, R. Villadsen, F. Rank, M. J. Bissell, and O. W. Petersen (2002). Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J. Cell Sci. 115: 39–50.
N. Koshikawa, G. Giannelli, V. Cirulli, K. Miyazaki, and V. Quaranta (2000). Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148: 615–624.
M. A. Deugnier, M. M. Faraldo, B. Janji, P. Rousselle, J. P. Thiery, and M. A. Glukhova (2002). EGF controls the in vivo developmental potential of a mammary epithelial cell line possessing progenitor properties. J. Cell Biol. 159: 453–463.
T. C. Klinowska, J. V. Soriano, G. M. Edwards, J. M. Oliver, A. J. Valentijn, and R. Montesano (1999). Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse. Dev. Biol. 215: 13–32.
T. Sakai, M. Larsen, and K. M. Yamada (2003). Fibronectin requirement in branching morphogenesis. Nature 423: 876–881.
B. S. Wiseman, M. D. Sternlicht, L. R. Lund, C. M. Alexander, J. Mott, M. J. Bissell, et al. (2003). Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J. Cell Biol. 162: 1123–1133.
V. Gouon-Evans, M. E. Rothenberg, and J. W. Pollard (2000). Postnatal mammary gland development requires macrophages and eosinophils. Development 127: 2269–2282.
K. Friedrichs, P. Ruiz, F. Franke, I. Gille, H. J. Terpe, and B. A. Imhof (1995). High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res. 55: 901–906.
U. M. Wewer, L. M. Shaw, R. Albrechtsen, and A. M. Mercurio (1997). The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. Am. J. Pathol. 151: 1191–1198.
A. M. Mercurio, R. E. Bachelder, J. Chung, K. L. O'Connor, I. Rabinovitz, and L. M. Shaw (2001). Integrin laminin receptors and breast carcinoma progression. J. Mammary Gland Biol. Neoplasia 6: 299–309.
K. L. O'Connor and A. M. Mercurio (2001). Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J. Biol. Chem. 276: 47895–47900.
I. Rabinovitz, I. K. Gipson, and A. M. Mercurio (2001). Traction forces mediated by alpha6beta4 integrin: Implications for basement membrane organization and tumor invasion. Mol. Biol. Cell 12: 4030–4043.
M. J. Arboleda, J. F. Lyons, F. F. Kabbinavar, M. R. Bray, B. E. Snow, and R. Ayala (2003). Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res. 63: 196–206.
M. Morini, M. Mottolese, N. Ferrari, F. Ghiorzo, S. Buglioni, and R. Mortarini (2000). The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer 87: 336–342.
T. Sugiura and F. Berditchevski (1999). Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J. Cell Biol. 146: 1375–1389.
A. Lochter, M. Navre, Z. Werb, and M. J. Bissell (1999). Alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol. Biol. Cell 10: 271–282.
E. I. Deryugina, B. Ratnikov, E. Monosov, T. I. Postnova, R. DiScipio, J. W. Smith, et al. (2001). MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res. 263: 209–223.
E. I. Deryugina, B. I. Ratnikov, T. I. Postnova, D. V. Rozanov, and A. Y. Strongin (2002). Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J. Biol. Chem. 277: 9749–9756.
B. I. Ratnikov, D. V. Rozanov, T. I. Postnova, P. G. Baciu, H. Zhang, R. G. DiScipio, et al. (2002). An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J. Biol. Chem. 277: 7377–7385.
B. Felding-Habermann, T. E. O'Toole, J. W. Smith, E. Fransvea, Z. M. Ruggeri, M. H. Ginsberg, et al. (2001). Integrin activation controls metastasis in human breast cancer. Proc. Natl. Acad. Sci. U.S.A. 98: 1853–1858.
M. Rolli, E. Fransvea, J. Pilch, A. Saven, and B. Felding-Habermann (2003). Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100: 9482–9487.
I. Pecheur, O. Peyruchaud, C. M. Serre, J. Guglielmi, C. Voland, F. Bourre, et al. (2002). Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J. 16: 1266–1368.
J. P. Thiery (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2: 442–454.
K. Kawano, S. S. Kantak, M. Murai, C. C. Yao, and R. H. Kramer (2001). Integrin alpha3beta1 engagement disrupts intercellular adhesion. Exp. Cell Res. 262: 180–196.
G. E. Plopper, S. Z. Domanico, V. Cirulli, W. B. Kiosses, and V. Quaranta (1998). Migration of breast epithelial cells on Laminin-5: Differential role of integrins in normal and transformed cell types. Breast Cancer Res. Treat. 51: 57–69.
G. E. Plopper, J. L. Huff, W. L. Rust, M. A. Schwartz, and V. Quaranta (2000). Antibody-induced activation of beta1 integrin receptors stimulates cAMP-dependent migration of breast cells on laminin-5. Mol. Cell Biol. Res. Commun. 4: 129–135.
Y. Wei, J. A. Eble, Z. Wang, J. A. Kreidberg, and H. A. Chapman (2001). Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol. Biol. Cell 12: 2975–2986.
F. Zhang, C. C. Tom, M. C. Kugler, T. T. Ching, J. A. Kreidberg, Y. Wei, et al. (2003). Distinct ligand binding sites in interne α 3β 1regulate matrix adhesion and cell-cell contact. J. Cell Biol. 163: 177–188.
N. A. Bhowmick, R. Zent, M. Ghiassi, M. McDonnell, and H. L. Moses (2001). Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276: 46707–46713.
D. Wang, L. Sun, E. Zborowska, J. K. Willson, J. Gong, J. Verraraghavan, et al. (1999). Control of type II transforming growth factor-beta receptor expression by integrin ligation. J. Biol. Chem. 274: 12840–12847.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taddei, I., Faraldo, M.M., Teulière, J. et al. Integrins in Mammary Gland Development and Differentiation of Mammary Epithelium. J Mammary Gland Biol Neoplasia 8, 383–394 (2003). https://doi.org/10.1023/B:JOMG.0000017426.74915.b9
Issue Date:
DOI: https://doi.org/10.1023/B:JOMG.0000017426.74915.b9